

Corteva vs Ambev
This page compares Corteva and Ambev, outlining their business models, financial performance, and market context to provide a neutral, accessible view of their strategies. It highlights key differences and similarities without speculation. Educational content, not financial advice.
This page compares Corteva and Ambev, outlining their business models, financial performance, and market context to provide a neutral, accessible view of their strategies. It highlights key difference...
Why It's Moving

Corteva Gears Up for Pivotal Q4 Earnings as Dividend Steady and Crop Momentum Builds.
- Board approved steady $0.18 quarterly dividend on January 28, payable March 16, underscoring strong cash flow and commitment to shareholders.
- Crop protection thrives on new tech demand and volume gains, while seeds benefit from hybrid innovations and pricing discipline across regions.
- Recent 12.55% revenue growth over three months outpaces Materials sector peers, bolstering expectations for earnings beat.

Ambev Faces Analyst Downgrade Pressure Amid Steady Trading Near 52-Week Highs
- Analysts issued a 'Reduce' rating with seven Holds and one Sell, signaling limited upside potential and weighing on investor sentiment.
- Stock opened at $2.78 with a $43.8B market cap and P/E of 15.45, trading above 50-day ($2.55) and 200-day ($2.38) moving averages.
- Recent special dividend of $0.049 per share paid in January bolsters yield appeal, even as Q3 revenue slightly missed estimates at $3.90B versus $3.97B expected.

Corteva Gears Up for Pivotal Q4 Earnings as Dividend Steady and Crop Momentum Builds.
- Board approved steady $0.18 quarterly dividend on January 28, payable March 16, underscoring strong cash flow and commitment to shareholders.
- Crop protection thrives on new tech demand and volume gains, while seeds benefit from hybrid innovations and pricing discipline across regions.
- Recent 12.55% revenue growth over three months outpaces Materials sector peers, bolstering expectations for earnings beat.

Ambev Faces Analyst Downgrade Pressure Amid Steady Trading Near 52-Week Highs
- Analysts issued a 'Reduce' rating with seven Holds and one Sell, signaling limited upside potential and weighing on investor sentiment.
- Stock opened at $2.78 with a $43.8B market cap and P/E of 15.45, trading above 50-day ($2.55) and 200-day ($2.38) moving averages.
- Recent special dividend of $0.049 per share paid in January bolsters yield appeal, even as Q3 revenue slightly missed estimates at $3.90B versus $3.97B expected.
Investment Analysis

Corteva
CTVA
Pros
- Corteva has shown strong first half 2025 results with raised full-year guidance and a leading North American corn and soybean seed portfolio.
- It leads agricultural innovation with advanced trait technologies, gene editing, hybrid wheat, and digital farming solutions driving long-term growth.
- The company has a robust market position in seeds and crop protection with solid revenue growth and projected operational EBITDA of $3.6-3.8 billion in 2025.
Considerations
- Its stock trades at a premium valuation with a P/E ratio above sector average, indicating potentially limited upside relative to peers.
- Profit margins remain moderate with net margin around 8.16%, which may limit profitability compared to industry standards.
- Recent insider selling and volatility in the stock price pose potential execution and market sentiment risks despite positive earnings.

Ambev
ABEV
Pros
- Ambev is the leading brewer in Latin America with a strong brand portfolio including Brahma, Skol, and Antarctica, offering wide regional market penetration.
- It benefits from consistent cash flow generation supported by high operating margins and effective cost control in a stable beverage sector.
- The company has exposure to growing emerging markets with potential to capitalise on increasing beer and soft drink consumption trends.
Considerations
- Ambev faces regulatory and macroeconomic risks such as tax changes, inflation, and currency fluctuations in Latin American markets.
- The beverage industry is highly competitive and cyclical, exposing Ambev to demand fluctuations and pricing pressure.
- Growth prospects could be constrained by saturation in key markets and limited diversification beyond alcoholic and non-alcoholic beverages.
Related Market Insights
Brazil's Global Champions: A Smarter Way to Invest in Latin America's Largest Economy
Invest in Brazil's economic growth through global companies with significant operations. Mitigate currency risk & capture long-term potential with Nemo's Brazil Global Champions Neme.
Aimee Silverwood | Financial Analyst
October 8, 2025
Related Market Insights
Brazil's Global Champions: A Smarter Way to Invest in Latin America's Largest Economy
Invest in Brazil's economic growth through global companies with significant operations. Mitigate currency risk & capture long-term potential with Nemo's Brazil Global Champions Neme.
Aimee Silverwood | Financial Analyst
October 8, 2025
Corteva (CTVA) Next Earnings Date
Corteva (CTVA)'s next earnings date is scheduled for February 3, 2026, after market close. This report will cover the fiscal quarter ending December 2025 (Q4 2025). Investors should monitor for the release and associated conference call, aligning with the company's historical quarterly pattern.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) has not officially confirmed its next earnings date, but estimates point to February 12, 2026, aligning with the company's historical pattern for Q4 2025 results. This release will cover the quarter ending December 2025, typically reported before market open. Investors should monitor official announcements for any updates, as dates can shift slightly.
Corteva (CTVA) Next Earnings Date
Corteva (CTVA)'s next earnings date is scheduled for February 3, 2026, after market close. This report will cover the fiscal quarter ending December 2025 (Q4 2025). Investors should monitor for the release and associated conference call, aligning with the company's historical quarterly pattern.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) has not officially confirmed its next earnings date, but estimates point to February 12, 2026, aligning with the company's historical pattern for Q4 2025 results. This release will cover the quarter ending December 2025, typically reported before market open. Investors should monitor official announcements for any updates, as dates can shift slightly.
Which Baskets Do They Appear In?
Brazil Investment Through Global Partners 2025
For Brazilians, investing in global companies with strong local operations may offer a way to manage domestic economic risks and currency fluctuations. This basket provides exposure to leading US and EU-listed blue-chip corporations that are deeply integrated into the Brazilian economy.
Published: October 8, 2025
Explore BasketWhich Baskets Do They Appear In?
Brazil Investment Through Global Partners 2025
For Brazilians, investing in global companies with strong local operations may offer a way to manage domestic economic risks and currency fluctuations. This basket provides exposure to leading US and EU-listed blue-chip corporations that are deeply integrated into the Brazilian economy.
Published: October 8, 2025
Explore BasketBuy CTVA or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons


Corteva vs Kimberly-Clark
Corteva vs Kimberly-Clark


Corteva vs Coca-Cola Europacific Partners
Corteva vs Coca-Cola Europacific Partners


Coca-Cola Europacific Partners vs Ambev
Coca-Cola Europacific Partners vs Ambev